Evidence map›Paper›PMID 31090437›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2019

Role of phospholipase D in bleomycin-induced mitochondrial reactive oxygen species generation, mitochondrial DNA damage, and pulmonary fibrosis.

Vidyani Suryadevara, Longshuang Huang, Seok-Jo Kim, Paul Cheresh, Mark Shaaya, Mounica Bandela, Panfeng Fu, Carol Feghali-Bostwick, Gilbert Di Paolo, David W Kamp and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. My Journey in Academia as a Lipid Biochemist.Cell biochemistry and biophysics · 2021
    Review
  17. Review
  18. Ras GEF Mouse Models for the Analysis of Ras Biology and Signaling.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Vidyani SuryadevaraDepartment of Bioengineering, University of Illinois at Chicago , Chicago, Illinois.ORCID 0000-0003-4081-2989
Longshuang HuangDepartment of Pharmacology, University of Illinois at Chicago , Chicago, Illinois.
Seok-Jo KimDepartment of Medicine, Division of Pulmonary and Critical Care Medicine, Northwestern University Feinberg School of Medicine and the Jesse Brown VA Medical Center , Chicago, Illinois.
Paul ChereshDepartment of Medicine, Division of Pulmonary and Critical Care Medicine, Northwestern University Feinberg School of Medicine and the Jesse Brown VA Medical Center , Chicago, Illinois.
Mark ShaayaDepartment of Pharmacology, University of Illinois at Chicago , Chicago, Illinois.
Mounica BandelaDepartment of Bioengineering, University of Illinois at Chicago , Chicago, Illinois.
Panfeng FuDepartment of Pharmacology, University of Illinois at Chicago , Chicago, Illinois.
Carol Feghali-BostwickMedical University of South Carolina , Charleston, South Carolina.
Gilbert Di PaoloDepartment of Pathology and Cell Biology, Columbia University Medical Center , New York, New York.
David W KampDepartment of Medicine, Division of Pulmonary and Critical Care Medicine, Northwestern University Feinberg School of Medicine and the Jesse Brown VA Medical Center , Chicago, Illinois.
Viswanathan NatarajanDepartment of Pharmacology, University of Illinois at Chicago , Chicago, Illinois.
University of Illinois Chicago · USNorthwestern University · USColumbia University Irving Medical Center · USMedical University of South Carolina · US

Funding

Northwestern University Clinical and Translational Science Institute (NUCATS)UL1TR001422 · NCATS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI D'AQUILA, RICHARD · 2015 to 2023
$56.8M
Therapeutic Potential of FTY720 Analogues in Lung InjuryP01HL098050 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI NATARAJAN, VISWANATHAN · 2011 to 2015
$10.9M
BLRD VA I01 BX000786NCATS NIH HHS UL1 TR001422NHLBI NIH HHS P01 HL098050
6 · The paper itself

Abstract

Idiopathic pulmonary fibrosis (IPF) is a pernicious lung disease characterized by alveolar epithelial apoptosis, dysregulated repair of epithelial injury, scar formation, and respiratory failure. In this study, we identified phospholipase D (PLD)-generated phosphatidic acid (PA) signaling in the development of pulmonary fibrosis (PF). Of the PLD isoenzymes, the protein expression of PLD2, but not PLD1, was upregulated in lung tissues from IPF patients and bleomycin challenged mice. Both PLD1 (

Indexed as

AnimalsBleomycinDNA DamageDNA, MitochondrialEpithelial CellsHumansIdiopathic Pulmonary FibrosisLungMice, TransgenicMitochondriaPhospholipase DReactive Oxygen SpeciesBleomycinDNA, MitochondrialPhospholipase DReactive Oxygen Speciesepithelial cell apoptosismitochondrial DNA damagemitochondrial ROSphosphatidic acidphospholipase Dpulmonary fibrosis

Identifiers

PMID31090437
PMCPMC6734379
OpenAlexW2945814659

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.